Medicine
Quinidine 324 mg extended-release tablet
Quinidine 324 mg extended-release tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Quinidine
- Brand
- Sold under the generic name
- Strength
- 324 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 250 tablets, 500 tablets and 6 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaEywa PharmaGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BA01 Quinidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 February 1987
- Identifiers
- RxCUI 852920DailyMed set ID 5023f053-fcc4-4c2c-aa59-9ec198ad185e, 4db375a3-0cff-4fa7-af7a-2a49e0b922d0, ad2ad985-cca2-25b5-e053-2995a90a402fNDC 53489-141, 71930-016, 51407-288Application ANDA089338, ANDA212589
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle, plastic | 53489-141-01 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 250 tablet, extended release in 1 bottle, plastic | 53489-141-03 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 500 tablet, extended release in 1 bottle, plastic | 53489-141-05 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 60 tablet, extended release in 1 bottle, plastic | 53489-141-06 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 30 tablet, extended release in 1 bottle, plastic | 53489-141-07 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 1000 tablet, extended release in 1 bottle, plastic | 53489-141-10 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 90 tablet, extended release in 1 bottle, plastic | 53489-141-90 | Sun Pharmaceutical IndustriesIndia | 10 February 1987 |
| 100 tablet, extended release in 1 bottle | 71930-016-12 | Eywa Pharma | 20 March 2022 |
| 100 tablet, extended release in 1 bottle, plastic | 51407-288-01 | Golden State Medical Supply | 24 October 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 July 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Quinidine
Clinical summary
Quinidine is an antiarrhythmic indicated as a means of restoring normal sinus rhythm, among other approved uses. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Quinidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about QuinidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- QUINIDINE SULFATE prescribing information (Epic Pharma) · U.S. National Library of Medicine, DailyMed
Need Quinidine 324 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.